SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
---|---|---|---|---|---|---|---|---|---|
20-Mar-24 8:07 PM View: | Grygiel Nancy A. SVP & CCO | Amgen Inc. (AMGN) | 18-Mar-24 | Payment of Exercise | 703 | $268.87 | $189,016.00 | (5%) 13.02K to 12.32K | |
20-Mar-24 8:05 PM View: | Griffith Peter H. EVP & CFO | Amgen Inc. (AMGN) | 18-Mar-24 | Payment of Exercise | 5,168 | $268.87 | $1,389,520.00 | (13%) 39.88K to 34.71K | |
20-Mar-24 8:00 PM View: | Gordon Murdo EVP, Global Commercial Ops | Amgen Inc. (AMGN) | 18-Mar-24 | Payment of Exercise | 6,461 | $268.87 | $1,737,170.00 | (11%) 57.78K to 51.32K | |
20-Mar-24 7:59 PM View: | Busch Matthew C. VP, Finance & CAO | Amgen Inc. (AMGN) | 18-Mar-24 | Payment of Exercise | 146 | $268.87 | $39,255.00 | (3%) 4.82K to 4.67K | |
20-Mar-24 8:12 PM View: | Santos Esteban EVP, Operations | Amgen Inc. (AMGN) | 18-Mar-24 | Payment of Exercise | 6,137 | $268.87 | $1,650,060.00 | (8%) 77.21K to 71.07K | |
20-Mar-24 8:09 PM View: | Khosla Rachna SVP, Business Development | Amgen Inc. (AMGN) | 18-Mar-24 | Payment of Exercise | 438 | $268.87 | $117,765.00 | (5%) 8.63K to 8.19K | |
20-Mar-24 8:04 PM View: | Graham Jonathan P EVP & Gen. Counsel & Secy. | Amgen Inc. (AMGN) | 18-Mar-24 | Payment of Exercise | 5,879 | $268.87 | $1,580,690.00 | (15%) 40.11K to 34.23K | |
20-Mar-24 8:10 PM View: | Miller Derek SVP, Human Resources | Amgen Inc. (AMGN) | 18-Mar-24 | Payment of Exercise | 475 | $268.87 | $127,713.00 | (5%) 8.89K to 8.42K | |
20-Mar-24 7:58 PM View: | Bradway Robert A Chairman, CEO and President Director | Amgen Inc. (AMGN) | 18-Mar-24 | Payment of Exercise | 20,560 | $268.87 | $5,527,970.00 | (3%) 684.64K to 664.08K | |
20-Mar-24 8:11 PM View: | Reese David M EVP & Chief Technology Officer | Amgen Inc. (AMGN) | 18-Mar-24 | Payment of Exercise | 6,202 | $268.87 | $1,667,530.00 | (9%) 66.87K to 60.67K | |
08-Mar-24 5:31 PM View: | Miller Derek SVP, Human Resources | Amgen Inc. (AMGN) | 06-Mar-24 | Grant | 1,311 | -- | -- | 17% 7.55K to 8.86K | |
08-Mar-24 5:23 PM View: | Bradway Robert A Chairman, CEO and President Director | Amgen Inc. (AMGN) | 06-Mar-24 | Grant | 41,133 | -- | -- | 6% 642.78K to 683.91K | |
08-Mar-24 5:32 PM View: | Reese David M EVP & Chief Technology Officer | Amgen Inc. (AMGN) | 06-Mar-24 | Grant | 12,407 | -- | -- | 23% 54.25K to 66.65K | |
08-Mar-24 5:29 PM View: | Grygiel Nancy A. SVP & CCO | Amgen Inc. (AMGN) | 06-Mar-24 | Grant | 1,954 | -- | -- | 18% 11.01K to 12.96K | |
08-Mar-24 5:27 PM View: | Griffith Peter H. EVP & CFO | Amgen Inc. (AMGN) | 06-Mar-24 | Grant | 10,338 | -- | -- | 36% 28.91K to 39.25K | |
08-Mar-24 5:25 PM View: | Gordon Murdo EVP, Global Commercial Ops | Amgen Inc. (AMGN) | 06-Mar-24 | Grant | 12,924 | -- | -- | 29% 44.65K to 57.57K | |
08-Mar-24 5:24 PM View: | Busch Matthew C. VP, Finance & CAO | Amgen Inc. (AMGN) | 06-Mar-24 | Grant | 418 | -- | -- | 10% 4.38K to 4.8K | |
08-Mar-24 5:34 PM View: | Santos Esteban EVP, Operations | Amgen Inc. (AMGN) | 06-Mar-24 | Grant | 12,278 | -- | -- | 19% 64.7K to 76.97K | |
08-Mar-24 5:30 PM View: | Khosla Rachna SVP, Business Development | Amgen Inc. (AMGN) | 06-Mar-24 | Grant | 1,256 | -- | -- | 17% 7.34K to 8.6K | |
08-Mar-24 5:26 PM View: | Graham Jonathan P EVP & Gen. Counsel & Secy. | Amgen Inc. (AMGN) | 06-Mar-24 | Grant | 11,760 | -- | -- | 42% 28.16K to 39.92K | |
12-Feb-24 7:50 PM View: | Bradner James E. EVP, R&D, & Chief Sci. Officer | Amgen Inc. (AMGN) | 09-Feb-24 | Grant | 22,393 | -- | -- | 100% 0 to 22.39K | |
04-Dec-23 7:41 PM View: | Grygiel Nancy A. SVP & CCO | Amgen Inc. (AMGN) | 04-Dec-23 | Private Sale | 2,096 | $273.03 | $572,276.00 | (16%) 13.07K to 10.97K | |
29-Nov-23 8:44 PM View: | Reese David M EVP, Research and Development | Amgen Inc. (AMGN) | 28-Nov-23 | Gift | 165 | -- | -- | (< 1%) 54.33K to 54.16K | |
13-Nov-23 8:30 PM View: | Graham Jonathan P EVP, Gen. Counsel & Secy. | Amgen Inc. (AMGN) | 08-Nov-23 | Private Sale | 10,000 | $272.81 | $2,728,140.00 | (26%) 38.08K to 28.08K | |
07-Nov-23 8:15 PM View: | Grygiel Nancy A. SVP & CCO | Amgen Inc. (AMGN) | 05-Nov-23 | Payment of Exercise | 249 | $269.86 | $67,195.10 | (2%) 13.32K to 13.07K | |
07-Nov-23 8:12 PM View: | Busch Matthew C. VP, Finance & CAO | Amgen Inc. (AMGN) | 05-Nov-23 | Payment of Exercise | 249 | $269.86 | $67,195.10 | (5%) 4.62K to 4.37K | |
07-Nov-23 8:16 PM View: | Khosla Rachna SVP, Business Development | Amgen Inc. (AMGN) | 05-Nov-23 | Payment of Exercise | 317 | $269.86 | $85,545.60 | (4%) 7.64K to 7.32K | |
07-Nov-23 8:20 PM View: | Miller Derek SVP, Human Resources | Amgen Inc. (AMGN) | 05-Nov-23 | Payment of Exercise | 66 | $269.86 | $17,810.80 | (< 1%) 7.6K to 7.53K | |
07-Nov-23 8:06 PM View: | Drake Michael V Director | Amgen Inc. (AMGN) | 03-Nov-23 | Grant | 241 | -- | -- | 12% 2.06K to 2.3K | |
07-Nov-23 8:10 PM View: | Ishrak Omar Director | Amgen Inc. (AMGN) | 03-Nov-23 | Grant | 241 | -- | -- | 7% 3.57K to 3.81K | |
07-Nov-23 8:09 PM View: | Holley Charles M Director | Amgen Inc. (AMGN) | 03-Nov-23 | Grant | 296 | -- | -- | 3% 9.54K to 9.84K | |
03-Nov-23 7:44 PM View: | Griffith Peter H. EVP & CFO | Amgen Inc. (AMGN) | 01-Nov-23 | Payment of Exercise | 3,502 | $255.70 | $895,461.00 | (11%) 32.32K to 28.82K | |
03-Nov-23 7:43 PM View: | Graham Jonathan P EVP, Gen. Counsel & Secy. | Amgen Inc. (AMGN) | 01-Nov-23 | Payment of Exercise | 1,751 | $255.70 | $447,731.00 | (4%) 39.83K to 38.08K | |
11-Aug-23 6:13 PM View: | Gordon Murdo EVP, Global Commercial Ops | Amgen Inc. (AMGN) | 10-Aug-23 | Private Sale | 9,558 | $262.43 | $2,508,310.00 | (18%) 53.87K to 44.31K | |
10-Aug-23 8:55 PM View: | Drake Michael V Director | Amgen Inc. (AMGN) | 08-Aug-23 | Grant | 125 | -- | -- | 7% 1.9K to 2.02K | |
10-Aug-23 8:56 PM View: | Ishrak Omar Director | Amgen Inc. (AMGN) | 08-Aug-23 | Grant | 125 | -- | -- | 4% 3.4K to 3.52K | |
10-Aug-23 8:57 PM View: | Holley Charles M Director | Amgen Inc. (AMGN) | 08-Aug-23 | Grant | 153 | -- | -- | 2% 9.24K to 9.39K | |
31-Jul-23 8:45 PM View: | Grygiel Nancy A. SVP & CCO | Amgen Inc. (AMGN) | 31-Jul-23 | Payment of Exercise | 1,129 | $236.37 | $266,862.00 | (8%) 14.32K to 13.19K | 3% |
23-May-23 7:24 PM View: | Ishrak Omar Director | Amgen Inc. (AMGN) | 19-May-23 | Grant | 939 | -- | -- | 38% 2.46K to 3.4K | |
23-May-23 7:22 PM View: | Holley Charles M Director | Amgen Inc. (AMGN) | 19-May-23 | Grant | 939 | -- | -- | 11% 8.3K to 9.24K | |
23-May-23 7:20 PM View: | Eckert Robert Director | Amgen Inc. (AMGN) | 19-May-23 | Grant | 939 | -- | -- | 4% 21.53K to 22.46K | |
23-May-23 7:17 PM View: | Austin Wanda M Director | Amgen Inc. (AMGN) | 19-May-23 | Grant | 939 | -- | -- | 19% 4.89K to 5.83K | |
23-May-23 7:19 PM View: | Druker Brian Director | Amgen Inc. (AMGN) | 19-May-23 | Grant | 939 | -- | -- | 20% 4.75K to 5.69K | |
23-May-23 7:27 PM View: | Miles Amy E Director | Amgen Inc. (AMGN) | 19-May-23 | Grant | 939 | -- | -- | 43% 2.18K to 3.12K | |
23-May-23 7:28 PM View: | Sugar Ronald D Director | Amgen Inc. (AMGN) | 19-May-23 | Grant | 939 | -- | -- | 5% 18.74K to 19.68K | |
23-May-23 7:21 PM View: | Garland Greg C. Director | Amgen Inc. (AMGN) | 19-May-23 | Grant | 939 | -- | -- | 9% 10.72K to 11.65K | |
23-May-23 7:29 PM View: | Williams R Sanders Director | Amgen Inc. (AMGN) | 19-May-23 | Grant | 939 | -- | -- | 18% 5.3K to 6.24K | |
23-May-23 7:18 PM View: | Drake Michael V Director | Amgen Inc. (AMGN) | 19-May-23 | Grant | 939 | -- | -- | 98% 0.96K to 1.9K | |
23-May-23 7:25 PM View: | Jacks Tyler Director | Amgen Inc. (AMGN) | 19-May-23 | Grant | 939 | -- | -- | 7% 13.93K to 14.87K | |
23-May-23 7:26 PM View: | Kullman Ellen Jamison Director | Amgen Inc. (AMGN) | 19-May-23 | Grant | 939 | -- | -- | 9% 10.27K to 11.21K |